Research programme: BNP aerosol - mondoBIOTECH

Drug Profile

Research programme: BNP aerosol - mondoBIOTECH

Alternative Names: Aerosolised brain natriuretic peptide - mondoBIOTECH; B-type natriuretic peptide - mondoBIOTECH; BNP

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator mondoBIOTECH
  • Class Heart failure therapies; Natriuretic peptides; Nerve tissue proteins
  • Mechanism of Action Diuretics
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Lung disorders

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Lung-disorders in Germany (Inhalation, Aerosol)
  • 17 Sep 2009 Preclinical development for Lung disorders in Germany (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top